Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

long-term condition

- PMLiVE

TOMORROW: Last chance to register for FREE Origins Webinar: How Patient Involvement is Transforming Clinical Trials – Reserve Your Spot Today!

Last chance to register for our exclusive webinar, “Why Patient Perspectives Matter: Driving Success in Clinical Trials”!   Wendy Erler and Alfred Samuels are ready to join Su Smith and...

Origins – The Patient Focused Specialists

- PMLiVE

Johnson & Johnson receives updated NICE recommendation for Tecvayli in multiple myeloma

Approximately 5,900 new cases of the blood cancer are diagnosed every year in the UK

- PMLiVE

Pfizer shares positive phase 3 results for Talzenna combination in prostate cancer

Up to 20% of patients will develop metastatic castration-resistant disease within five to seven years of diagnosis

- PMLiVE

Roche presents two-year data for spinal muscular atrophy treatment Evrysdi in children

The severe and progressive neuromuscular disease affects about one in every 10,000 babies

- PMLiVE

Eli Lilly and insitro collaborate to advance new treatments for metabolic diseases

Metabolic dysfunction-associated steatotic liver disease is estimated to affect 100 million people in the US

- PMLiVE

GSK’s RSV vaccine Arexvy shown to protect older adults across three seasons

The respiratory virus is estimated to impact 64 million people globally every year

- PMLiVE

Roche’s Itovebi combination granted FDA approval for advanced breast cancer

Approximately 310,720 women will be diagnosed with invasive breast cancer in the US this year

- PMLiVE

Merck and Astellas/Pfizer’s bladder cancer combination receives MHRA approval

About 614,000 people are diagnosed with bladder cancer globally every year

- PMLiVE

PM Society Awards 2025 open for entries

The ceremony will be held at JW Marriott Grosvenor House in London on 14 March

- PMLiVE

Behavioural Data Offering from Medscape Global

See more about this new insights product, Medscape AffinityTM, which offers unparalleled insights into the online behaviour of 13M+ HCPs to help you make fully informed decisions around your brand and content...

Medscape Medical Affairs

- PMLiVE

Ipsen’s Iqirvo approved by MHRA to treat primary biliary cholangitis in adults

Approximately 25,000 people in the UK are affected by the rare liver disease

- PMLiVE

PMLiVE’s T40 – results announced!

The list highlights the creative agencies that had the most impact on the UK healthcare sector in 2023

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links